13th Global Pharmacovigilance and clinical trials summit

    Global Pharmacovigilance and clinical trials summit

    Date(s) - 28/03/2019 - 29/03/2019
    12:00 am


    Location Address 1-13-11 Nanko-Kita, Suminoe-Ku, Osaka, Japan, 559-0034, Osaka

    City Osaka

    Country/State Japan


    With the excellent accomplishment of Pharmacovigilance Series of Conferences in the UK, the USA in back to back a long time in the course of the most recent quite a while which met with extraordinary accomplishment in Business Conferencing.

    It’s happy to report thirteenth Global Pharmacovigilance and Drug Safety Summit amid March 28-29, 2019 Osaka, Japan with the topic ‘’Promulgating the prevention of adverse drug reaction”. This is a 2-day Mega Event offering Exhibition, at the scene to grandstand the new and rising advancements with Keynote introduction, Oral, YRF (Student Presentation), blurb, e-publication Presentations.

    We are happy to educate you that the Speaker/Delegate/Exhibitor openings are accessible at the meeting. kindly visit the website of the conference to find out about the scientific sessions and abstract submission, If needs to go to as Delegate, sympathetically enroll to the gathering. For any questions, mail us.

    Our Confirmed Speakers:

    Keynote:(Day 1)

    Dr.Jacob Joseph, Harward Medical School, USA

    Dr.Ujwala Salvi, Nucleon Therapeutics, India

    Dr.Omer, Sanofi, Canada

    Dr.Ashok, Clinfomatrix, USA

    Other Speakers

    Mr.Chi Chen, E&Y, China

    Dr.Meenal Patwardhan, Abbvie, USA

    Mr.Rajiv Joshi, E&Y, India

    Keynote (Day 2)

    Dr.Essam, Celyad, Belgium

    Dr.Carole, Sun Pharma, Japan

    Mr.Robert, Accenture, Spain

    Session Speakers:

    Mr.Ravish Kumar, Salzman Group, Australia

    Dr.Abdeen, Ministry of health, UK.

    Dr.Ripal Gharia, Cliantha research, India

    Mr.Mohammed Gayoor khan,NFPS,Malaysia

    Participating Companies:

             Abbvie,USA

             E&Y, China

             Salmanz Group, Australia

             Nucleon Therapetics, India

             Saudi Patient safety Center, Saudi

             AlphaBeta Pharma, UK

             King Abdullah Medical City (KAMC)

             Takeda, USA

    Please let me know your confirmation at the earliest convenience.

      Best Regards
    Zoey A Williams| Program Coordinator
    Global Pharmacovigilance 2019
    Ph: 4896666555 Ext:6028
    Email:  [email protected]

    If you like this article, please help us by making a donation so that we can continue our work. Please help keep us independent.

    Previous article13th Abuja International Housing Show 2019
    Next articleChina’s ‘One Belt One Road’ Initiative and the EU: Panel Debate


    Please enter your comment!
    Please enter your name here

    This site uses Akismet to reduce spam. Learn how your comment data is processed.